Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,501 to 1,520 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate. | Nat Commun | 2020 | 32839463 | PubTator, text mining | PubMed |
| Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop. | J Cell Mol Med | 2020 | 32827244 | PubTator, text mining | PubMed |
| A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis. | Chin Med J (Engl) | 2020 | 32826458 | PubTator, text mining | PubMed |
| lncRNA TUG1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma via Regulating miR-29c-3p/COL1A1 Axis. | Cancer Manag Res | 2020 | 32821161 | PubTator, text mining | PubMed |
| Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer. | Cell Death Dis | 2020 | 32820148 | PubTator, text mining | PubMed |
| Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice. | Sci Transl Med | 2020 | 32817366 | PubTator, text mining | PubMed |
| GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival. | Technol Cancer Res Treat | 2020 | 32812493 | PubTator, text mining | PubMed |
| A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27. | Oncogene | 2020 | 32811980 | PubTator, text mining | PubMed |
| Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi. | Nat Commun | 2020 | 32796823 | PubTator, text mining | PubMed |
| Generation of a serine/threonine-protein kinase LATS1 gene-edited iPSC MUSIi012-A-3. | Stem Cell Res | 2020 | 32791482 | PubTator, text mining | PubMed |
| Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma. | Int J Med Sci | 2020 | 32788868 | PubTator, text mining | PubMed |
| Research progress regarding the role of long non-coding RNAs in osteosarcoma. | Oncol Lett | 2020 | 32782578 | PubTator, text mining | PubMed |
| Effect of YAP/TAZ on megakaryocyte differentiation and platelet production. | Biosci Rep | 2020 | 32779719 | PubTator, text mining | PubMed |
| The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression. | Cell Prolif | 2020 | 32779318 | PubTator, text mining | PubMed |
| Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice. | J Exp Clin Cancer Res | 2020 | 32778157 | PubTator, text mining | PubMed |
| microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors. | Cancer Treat Res Commun | 2020 | 32777750 | PubTator, text mining | PubMed |
| LDL receptor-related protein LRP6 senses nutrient levels and regulates Hippo signaling. | EMBO Rep | 2020 | 32767654 | PubTator, text mining | PubMed |
| The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells. | Nat Commun | 2020 | 32764536 | PubTator, text mining | PubMed |
| Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology. | Int J Biol Sci | 2020 | 32760212 | PubTator, text mining | PubMed |
| Perspectives on the Role of Non-Coding RNAs in the Regulation of Expression and Function of the Estrogen Receptor. | Cancers (Basel) | 2020 | 32759784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=76